The over-expression of HULC contributes to the malignant development of hepatocellular carcinoma by supporting abnormal lipid metabolism via activation of the acyl-CoA synthetase subunit ACSL1. This results in promotion of lipogenesis and the accumulation of intracellular triglycerides and cholesterol in experimental models. Here, ACSL1 is linked to hepatocellular carcinoma.